General Hospital Of Shenyang Military Region
Clinical trials sponsored by General Hospital Of Shenyang Military Region, explained in plain language.
-
Heart drug may worsen advanced liver disease – major trial underway
Disease control Not yet recruitingThis study looks at whether propranolol, a drug often used for high blood pressure, helps or harms people with advanced cirrhosis (severe liver scarring). The trial will include 466 adults with a MELD score over 9, meaning their liver disease is fairly advanced. Researchers will …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Which drug works best for cirrhosis patients with bleeding and kidney trouble?
Disease control Not yet recruitingThis study compares two drugs, terlipressin and somatostatin, in 64 adults with liver cirrhosis who have acute gastrointestinal bleeding and acute kidney injury. Both drugs are given intravenously for up to 5 days. The main goal is to see which drug better reverses kidney injury.…
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Which numbing agent wins for a more comfortable throat scope?
Symptom relief Not yet recruitingThis trial compares two common throat-numbing medicines—dyclonine hydrochloride mucilage and tetracaine hydrochloride jelly—to see which one works better for reducing discomfort during an unsedated gastroscopy. About 208 adults scheduled for the procedure will receive one of the …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC